DOCSLIB.ORG

Solutions Your Api Intermediates

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Solutions Your Api Intermediates Price list All products SMART SOLUTIONS YOUR API INTERMEDIATES Smart Solutions GmbH Dr. Kurt - Schumacher Straße 19 90402 Nürnberg Tel.: 0911 / 211 025 0 [email protected] Preise vom 14.10.2020 All products (-)-trans-delta-9-Tetrahydrocannabinol (Dronabinol Art.Nr. BTM14904 price [USD ($)] (3,4-Methylenedioxyphenyl)-2-methylaminopropan-1-o Art.Nr. BTM14753 price [USD ($)] (Naphtalen-1-yl)(1-butyl-1H-indol-3-yl)methanon Art.Nr. BTM14780 price [USD ($)] (Naphtalen-1-yl)(1-hexyl-1H-indol-3-yl)methanon Art.Nr. BTM14781 price [USD ($)] (Naphtalen-1-yl)(1-pentyl-1H-indol-3yl)methanon Art.Nr. BTM14782 price [USD ($)] 1-(1-Phenyl-cyclohexyl)-pyrrolidin Art.Nr. BTM14856 price [USD ($)] 1-(2-Chlorphenyl)piperazin / o-Chlorphen Art.Nr. BTM14485 price [USD ($)] 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidin Art.Nr. BTM14857 price [USD ($)] 1-(3,4,5-Trimethoxyphenyl)-2-aminoethan Art.Nr. BTM14925 price [USD ($)] 1-(3-Chloropropyl)-4-methylpiperazine (CAS: 104-16 Art.Nr. 8369 price [USD ($)] (CAS: 104-16-5) 1290.00 1-(3-Chlorphenyl)piperazin / m-Chlorphen Art.Nr. BTM14486 price [USD ($)] 1-(3-Trifluoromethylphenyl)piperazin Art.Nr. BTM14920 price [USD ($)] 1-(4-Chlorphenyl)piperazin / p-Chlorphen Art.Nr. BTM14487 price [USD ($)] 1-(4-Fluorophenyl)propan-2-amin Art.Nr. BTM14639 price [USD ($)] 1-Benzylpiperazin dihydrochlorid (CAS: 5321-63-1) Art.Nr. BTM14463 price [USD ($)] 1-Hydroxy-3-(1,2-dimethylheptyl)-7,8,9,10-tetrahyd Art.Nr. BTM14656 price [USD ($)] 1-Hydroxy-3-n-hexyl-7,8,9,10-tetrahydro-6,6,9-trim Art.Nr. BTM14660 price [USD ($)] 1-Methyl-4-phenyl-4-propionoxypiperidin (MPPP) Art.Nr. BTM14743 price [USD ($)] 1-Pentyl-3-(1-Naphthoyl)indol siehe unter JWH-018 Art.Nr. BTM14825 price [USD ($)] 1-Pentyl-3-(2-methoxyphenylacetyl)indol siehe unt Art.Nr. BTM14824 price [USD ($)] 1-[1-(2-Thienyl)-cyclohexyl]-piperidin siehe unte Art.Nr. BTM14912 price [USD ($)] 17a-Estradiol (CAS: 57-91-0) Art.Nr. 8105 price [USD ($)] 2,4,5-Trimethoxyamphetamin (TMA-2) (CAS: 1083-09-6 Art.Nr. BTM14924 price [USD ($)] 2,5-Dimethoxy-4-(n)-propylthiophenethylamin Art.Nr. BTM14573 price [USD ($)] 2,5-Dimethoxy-4-ethylamphetamin (DOET) [(±)-Isomer Art.Nr. BTM14569 price [USD ($)] 2,5-Dimethoxy-4-methylamphetamin (DOM, STP) [(±)-I Art.Nr. BTM14570 price [USD ($)] 2,5-Dimethoxy-4-methylamphetamin-hydrochlorid Art.Nr. BTM14571 price [USD ($)] 2,5-Dimethoxyamphetamin (DMA) (CAS: 2801-68-5 ) Art.Nr. BTM14568 price [USD ($)] 2,5-dimethoxy-4-iodo-phenethylamin (2C-I) Art.Nr. BTM14572 price [USD ($)] 2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanon Art.Nr. BTM14739 price [USD ($)] 2-(Dimethylamino) ethyl Chloride HCI Art.Nr. 8307 price [USD ($)] Quality:: Tech / 2kg 490.00 2-(Methylamino)-1-phenylpropan-1-on Art.Nr. BTM14744 price [USD ($)] 2-Amino-1-(2,5-dimethoxy-4-methyl)-phenyl-propan Art.Nr. BTM14437 price [USD ($)] 2-Amino-5-nitrothiazole (CAS 121-66-4) Art.Nr. 8003 price [USD ($)] 2-Aminopropiophenon Art.Nr. BTM14440 price [USD ($)] 2-Butoxyethanol (CAS: 111-76-2) Art.Nr. 8376 price [USD ($)] Quality:: Tech / 1liter 400.00 2-Methylamino-1-(3,4-methylenedioxyphenyl)butan-1- Art.Nr. BTM14740 price [USD ($)] 3,4,5-Trimethoxyamphetamin (TMA) (CAS: 1082-88-8 ) Art.Nr. BTM14923 price [USD ($)] 3,4-Methylendioxyamphetamin (MDA) [(±)-Isomer] Art.Nr. BTM14748 price [USD ($)] 3,4-Methylendioxyamphetamin-hydrochlorid Art.Nr. BTM14749 price [USD ($)] 3,4-Methylendioxymethamphetamin (MDMA) [(±)-Isomer Art.Nr. BTM14750 price [USD ($)] 3,4-Methylendioxymethamphetamin-hydrochlorid Art.Nr. BTM14751 price [USD ($)] 3,4-Methylenedioxypyrovaleron (MDPV) Art.Nr. BTM14754 price [USD ($)] 3-(2-Aminobutyl)-indol siehe unter Etryptamin Art.Nr. BTM14439 price [USD ($)] 3-(2-Diethylaminoethyl)-indol Art.Nr. BTM14543 price [USD ($)] 3-(2-Dimethylaminoethyl)-indol Art.Nr. BTM14574 price [USD ($)] 3-(Ethylmercapto)-aniline (CAS: 1783-82-0) Art.Nr. 8311 price [USD ($)] Quality:: Tech 98% / 500g 4900.00 3-Methylfentanyl (CAS: 42045-86-3 ) Art.Nr. BTM14756 price [USD ($)] 3-Methylthiofentanyl (CAS: 86052-04-2 ) Art.Nr. BTM14762 price [USD ($)] 3-Methylthiofentanyl-hydrochlorid (cis-Isomer) Art.Nr. BTM14763 price [USD ($)] 3-mercapto, 4-butylphenol Art.Nr. 10000 price [USD ($)] 4-(1H-1,2,4-Triazol-1-ylmethyl)benzenamine Art.Nr. 10001 price [USD ($)] 4-(dicyanomethylene)-2,6-dimethyl-4H-pyran Art.Nr. 10002 price [USD ($)] 4-Aminopyridine/Fampridin / Pharma Art.Nr. 8122 price [USD ($)] Geprüfte Identität, kein GID da / 50g 470.00 keine Pharmakopöe / 100g 910.00 / 200g 1790.00 4-Brom-2,5-dimethoxyamphetamin (DOB) [(±)-Isomer] Art.Nr. BTM14472 price [USD ($)] 4-Brom-2,5-dimethoxyamphetamin-hydrochlorid (DOB-h Art.Nr. BTM14473 price [USD ($)] 4-Brom-2,5-dimethoxyphenylethylamin (2C-B) Art.Nr. BTM14474 price [USD ($)] 4-Brom-2,5-dimethoxyphenylethylamin-hydrochlorid Art.Nr. BTM14475 price [USD ($)] 4-Bromopyridin-2-ylamine (CAS: 84249-14-9) Art.Nr. 10005 price [USD ($)] 4-Ethylthio-2,5-dimethoxyphenethylamin (2 C-T-2) Art.Nr. BTM14614 price [USD ($)] 4-Fluoroamphetamin (CAS: 459-02-9 ) Art.Nr. BTM14637 price [USD ($)] 4-Hydroxybuttersäure (GHB) (CAS: 591-81-1 ) Art.Nr. BTM14661 price [USD ($)] 4-Hydroxybuttersäure-Ca (GHB-Ca) Art.Nr. BTM14662 price [USD ($)] 4-Hydroxybuttersäure-K (GHB-K) (CAS: 57769-01-4 ) Art.Nr. BTM14663 price [USD ($)] 4-Hydroxybuttersäure-Na (GHB-Na) (CAS: 502-85-2 ) Art.Nr. BTM14664 price [USD ($)] 4-MTA siehe unter 4-Methylthioamphetamin Art.Nr. BTM14777 price [USD ($)] 4-Methylaminorex (CAS: 3568-94-3 ) Art.Nr. BTM14745 price [USD ($)] 4-Methylthioamphetamin (4-MTA) (CAS: 14116-06-4 ) Art.Nr. BTM14759 price [USD ($)] 4-phenylbutryric acid sodium salt Art.Nr. 10006 price [USD ($)] 4-[1-(4-Chlorophenyl)-1-(2-pyridyl)methoxy]piperid Art.Nr. 10003 price [USD ($)] 4-[4-[1-(4-Chlorophenyl)-1-(2-pyridyl)methoxy]pipe Art.Nr. 10004 price [USD ($)] 5-(4-chlorobutyl)-1-cyclohexyl-1h-tetrazole Art.Nr. 10007 price [USD ($)] 5-ALA HCI Reference Standard Compound A Art.Nr. 8621 price [USD ($)] CAS: 77479-08-8 / 1.5g 1800.00 5-ALA HCI Reference Standard Compound B Art.Nr. 8622 price [USD ($)] CAS: 109258-71-1 / 5g 2600.00 5-Aminolevulinic acid hcl (CAS: 5451-09-2) Art.Nr. 8116 price [USD ($)] Quality:: USP 5-Aminolevulinic acid HCL / USP/ 350.00 GID / 10g 5-Aminolevulinic acid HCL / USP/ 3300.00 GID / 100g 5-Benzyloxyindol (CAS: 1215-59-4) Art.Nr. 8487 price [USD ($)] Quality:: TECH 98% / 250g 950.00 5-Hydroxytryptophan (CAS 314062-44-7) Art.Nr. 10008 price [USD ($)] 5-Methoxy-3,4-methylendioxyamphetamin (MMDA) Art.Nr. BTM14737 price [USD ($)] 6-hydroxy-3,4-dihydro-quinolin-2-one Art.Nr. 10010 price [USD ($)] 6-beta-Naltrexol (CAS 49625-89-0) Art.Nr. 8614 price [USD ($)] 5g / TECH-GRADE 3875.00 ABACAVIR Art.Nr. 10011 price [USD ($)] ABAMECTIN Art.Nr. 10012 price [USD ($)] ABOB Art.Nr. 10013 price [USD ($)] Aca (7-amino cefalosporic acid) Art.Nr. 10014 price [USD ($)] ACAMPROSATE CALCIUM Art.Nr. 10015 price [USD ($)] ACARBOSE Art.Nr. 10016 price [USD ($)] ACEBUTOLOL Art.Nr. 10017 price [USD ($)] ACECAINIDE HCL Art.Nr. 10018 price [USD ($)] ACECLIDINE HCL Art.Nr. 10019 price [USD ($)] ACECLIDINE INTERMEDIATE Art.Nr. 10020 price [USD ($)] ACECLOFENAC Art.Nr. 10021 price [USD ($)] ACEDIASULFONE SODIUM Art.Nr. 10022 price [USD ($)] ACEFYLLINE Art.Nr. 10023 price [USD ($)] ACEFYLLINE HEPTAMINOL Art.Nr. 10024 price [USD ($)] ACEFYLLINE PIPERAZINE Art.Nr. 10025 price [USD ($)] ACEGLUTAMIDE Art.Nr. 10026 price [USD ($)] ACEMETACIN Art.Nr. 10027 price [USD ($)] ACENOCOUMAROL Art.Nr. 10028 price [USD ($)] Quality: BP / 100g 990.00 ACEPHATE Art.Nr. 10029 price [USD ($)] ACEPROMAZINE Art.Nr. 10030 price [USD ($)] ACEPROMAZINE MALEATE Art.Nr. 10031 price [USD ($)] ACEPROMETAZINE MALEATE Art.Nr. 10032 price [USD ($)] ACEQUINOCYL Art.Nr. 10033 price [USD ($)] ACESULFAME POTASSIUM Art.Nr. 10034 price [USD ($)] Acetamide iminodiacetic acid (ada) Art.Nr. 10035 price [USD ($)] ACETARSOL Art.Nr. 10036 price [USD ($)] ACETARSOL BASE Art.Nr. 10037 price [USD ($)] ACETARSOL SODIUM Art.Nr. 10038 price [USD ($)] ACETINOMYCIN D Art.Nr. 10039 price [USD ($)] ACETOHEXAMIDE Art.Nr. 10040 price [USD ($)] Acetohydroxamic acid (cas: 546-88-3) Art.Nr. 10041 price [USD ($)] Acetomenaphtone / menadiol diacetate Art.Nr. 10042 price [USD ($)] ACETOXYQUINUCLIDINE HCL Art.Nr. 10044 price [USD ($)] ACETRIZOIC ACID Art.Nr. 10045 price [USD ($)] ACETYL SULFA THIAZOL Art.Nr. 10046 price [USD ($)] Acetylamino succinate bi-potassium salt Art.Nr. 10047 price [USD ($)] ACETYLCARNITINE Art.Nr. 10048 price [USD ($)] ACETYLCHOLINE CHLORIDE Art.Nr. 10049 price [USD ($)] ACETYLDIGITOXIN Art.Nr. 10050 price [USD ($)] ACETYLDIGOXIN Art.Nr. 10051 price [USD ($)] ACETYLGLUCOSAMINE (N-D-) Art.Nr. 10053 price [USD ($)] ACETYLGLUTAMINE (N-L-) Art.Nr. 10054 price [USD ($)] ACETYLHYDROCODEINE Art.Nr. 10055 price [USD ($)] ACETYLINDOL (1-ACETYLINDOL-3-ol) Art.Nr. 10056 price [USD ($)] ACETYLKITASAMYCIN Art.Nr. 10057 price [USD ($)] ACETYLLEUCINE (N-DL) Art.Nr. 10058 price [USD ($)] Acetylleucine (n-dl) (cas:99-15-0) Art.Nr. 10059 price [USD ($)] ACETYLLEUCINE (N-L) Art.Nr. 10060 price [USD ($)] ACETYLMETHIONINE(-DL) Art.Nr. 10061 price [USD ($)] ACETYLPROMAZIN MALEATE Art.Nr. 10062 price [USD ($)] ACETYLSALICYLAMIDE Art.Nr. 10063 price [USD ($)] ACETYLSPYRAMYCIN Art.Nr. 10064 price [USD ($)] ACETYLSULFISOXAZOLE Art.Nr. 10065 price [USD ($)] Acetylthiazolidine-4-carboxylic ac.(-l-) Art.Nr. 10066 price [USD ($)] ACETYLTRYPTOPHANE Art.Nr. 10067 price [USD ($)] ACETYLTYROSINE (N-L-) Art.Nr. 10068 price [USD ($)] ACETYLUREA (MONO-) Art.Nr. 10069 price [USD ($)] ACEXAMATE CALCIUM Art.Nr. 10070 price [USD ($)] ACEXAMATE SODIUM Art.Nr. 10071
Load more

Recommended publications
  • Meprobamate Art 107 AR
    30 March 2012 EMA/212617/2012 Assessment report for meprobamate-containing medicinal products for oral use Procedure number: EMEA/H/A-107/1316 Procedure under Article 107 of Directive 2001/83/EC, as amended Assessment Report as adopted by the CHMP with all information of a commercially confidential nature deleted. 7 Westferry Circus ● Canary Wharf ● London E14 4HB ● United Kingdom Telephone +44 (0)20 7418 8400 Facsimile +44 (0)20 7523 7051 E -mail [email protected] Website www.ema.europa.eu An agency of the European Union © European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged. Table of contents 1. Background information on the procedure .............................................. 3 1.1. Referral of the matter to the CHMP ......................................................................... 3 2. Scientific discussion ................................................................................ 3 2.1. Introduction......................................................................................................... 3 2.2. Discussion on safety ............................................................................................. 4 2.2.1. Non-clinical data ................................................................................................ 4 2.2.2. Clinical safety .................................................................................................... 4 2.2.2.1. Clinical studies ..............................................................................................
    [Show full text]
  • Amnestic Concentrations of Sevoflurane Inhibit Synaptic
    Anesthesiology 2008; 108:447–56 Copyright © 2008, the American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Amnestic Concentrations of Sevoflurane Inhibit Synaptic Plasticity of Hippocampal CA1 Neurons through ␥-Aminobutyric Acid–mediated Mechanisms Junko Ishizeki, M.D.,* Koichi Nishikawa, M.D., Ph.D.,† Kazuhiro Kubo, M.D.,‡ Shigeru Saito, M.D., Ph.D.,§ Fumio Goto, M.D., Ph.D.࿣ Background: The cellular mechanisms of anesthetic-induced for surgical procedures do not have recollection of ac- amnesia are still poorly understood. The current study exam- tually being awake despite being awake and cooperative ined sevoflurane at various concentrations in the CA1 region of during the procedure.1 Galinkin et al.2 compared sub- rat hippocampal slices for effects on excitatory synaptic trans- Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/108/3/447/366512/0000542-200803000-00017.pdf by guest on 29 September 2021 mission and on long-term potentiation (LTP), as a possible jective, psychomotor, cognitive, and analgesic effects of mechanism contributing to anesthetic-induced loss of recall. sevoflurane (0.3% and 0.6%) with those of nitrous oxide Methods: Population spikes and field excitatory postsynaptic at equal minimum alveolar concentrations (MACs) in potentials were recorded using extracellular electrodes after healthy volunteers. They found that sevoflurane pro- electrical stimulation of Schaffer-collateral-commissural fiber inputs. Paired pulse facilitation was used as a measure of pre- duced a greater degree of amnesia and psychomotor synaptic effects of the anesthetic. LTP was induced using tetanic impairment than did an equal MAC of nitrous oxide but stimulation (100 Hz, 1 s). Sevoflurane at concentrations from had no analgesic actions.
    [Show full text]
  • Guidelines for the Forensic Analysis of Drugs Facilitating Sexual Assault and Other Criminal Acts
    Vienna International Centre, PO Box 500, 1400 Vienna, Austria Tel.: (+43-1) 26060-0, Fax: (+43-1) 26060-5866, www.unodc.org Guidelines for the Forensic analysis of drugs facilitating sexual assault and other criminal acts United Nations publication Printed in Austria ST/NAR/45 *1186331*V.11-86331—December 2011 —300 Photo credits: UNODC Photo Library, iStock.com/Abel Mitja Varela Laboratory and Scientific Section UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Guidelines for the forensic analysis of drugs facilitating sexual assault and other criminal acts UNITED NATIONS New York, 2011 ST/NAR/45 © United Nations, December 2011. All rights reserved. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. This publication has not been formally edited. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. List of abbreviations . v Acknowledgements .......................................... vii 1. Introduction............................................. 1 1.1. Background ........................................ 1 1.2. Purpose and scope of the manual ...................... 2 2. Investigative and analytical challenges ....................... 5 3 Evidence collection ...................................... 9 3.1. Evidence collection kits .............................. 9 3.2. Sample transfer and storage........................... 10 3.3. Biological samples and sampling ...................... 11 3.4. Other samples ...................................... 12 4. Analytical considerations .................................. 13 4.1. Substances encountered in DFSA and other DFC cases .... 13 4.2. Procedures and analytical strategy...................... 14 4.3. Analytical methodology .............................. 15 4.4.
    [Show full text]
  • Picrotoxin-Like Channel Blockers of GABAA Receptors
    COMMENTARY Picrotoxin-like channel blockers of GABAA receptors Richard W. Olsen* Department of Molecular and Medical Pharmacology, Geffen School of Medicine, University of California, Los Angeles, CA 90095-1735 icrotoxin (PTX) is the prototypic vous system. Instead of an acetylcholine antagonist of GABAA receptors (ACh) target, the cage convulsants are (GABARs), the primary media- noncompetitive GABAR antagonists act- tors of inhibitory neurotransmis- ing at the PTX site: they inhibit GABAR Psion (rapid and tonic) in the nervous currents and synapses in mammalian neu- system. Picrotoxinin (Fig. 1A), the active rons and inhibit [3H]dihydropicrotoxinin ingredient in this plant convulsant, struc- binding to GABAR sites in brain mem- turally does not resemble GABA, a sim- branes (7, 9). A potent example, t-butyl ple, small amino acid, but it is a polycylic bicyclophosphorothionate, is a major re- compound with no nitrogen atom. The search tool used to assay GABARs by compound somehow prevents ion flow radio-ligand binding (10). through the chloride channel activated by This drug target appears to be the site GABA in the GABAR, a member of the of action of the experimental convulsant cys-loop, ligand-gated ion channel super- pentylenetetrazol (1, 4) and numerous family. Unlike the competitive GABAR polychlorinated hydrocarbon insecticides, antagonist bicuculline, PTX is clearly a including dieldrin, lindane, and fipronil, noncompetitive antagonist (NCA), acting compounds that have been applied in not at the GABA recognition site but per- huge amounts to the environment with haps within the ion channel. Thus PTX major agricultural economic impact (2). ͞ appears to be an excellent example of al- Some of the other potent toxicants insec- losteric modulation, which is extremely ticides were also radiolabeled and used to important in protein function in general characterize receptor action, allowing and especially for GABAR (1).
    [Show full text]
  • California Essential Drug List
    California Essential Drug List The Essential Drug List (formulary) includes a list of drugs covered by Health Net. The drug list is updated at least monthly and is subject to change. All previous versions are no longer in effect. You can view the most current drug list by going to our website at www.healthnet.com. Refer to Evidence of Coverage or Certificate of Insurance for specific cost share information. For California Individual & Family Plans: Drug Lists Select Health Net Large Group – Formulary (pdf). For Small Business Group: Drug Lists Select Health Net Small Business Group – Formulary (pdf). NOTE: To search the drug list online, open the (pdf) document. Hold down the “Control” (Ctrl) and “F” keys. When the search box appears, type the name of your drug and press the “Enter” key. If you have questions or need more information call us toll free. California Individual & Family Plans (off-Exchange) If you have questions about your pharmacy coverage call Customer Service at 1-800-839-2172 California Individual & Family Plans (on-Exchange) If you have questions about your pharmacy coverage call Customer Service at 1-888-926-4988 Hours of Operation 8:00am – 7:00pm Monday through Friday 8:00am – 5:00pm Saturday Small Business Group If you have questions about your pharmacy coverage call Customer Service at 1-800-361-3366 Hours of Operation 8:00am – 6:00pm Monday through Friday Updated September 1, 2021 Health Net of California, Inc. and Health Net Life Insurance Company are subsidiaries of Health Net, LLC and Centene Corporation. Health Net is a registered service mark of Health Net, LLC Table of Contents What If I Have Questions Regarding My Pharmacy Benefit? ...................................
    [Show full text]
  • Customs Tariff - Schedule
    CUSTOMS TARIFF - SCHEDULE 99 - i Chapter 99 SPECIAL CLASSIFICATION PROVISIONS - COMMERCIAL Notes. 1. The provisions of this Chapter are not subject to the rule of specificity in General Interpretative Rule 3 (a). 2. Goods which may be classified under the provisions of Chapter 99, if also eligible for classification under the provisions of Chapter 98, shall be classified in Chapter 98. 3. Goods may be classified under a tariff item in this Chapter and be entitled to the Most-Favoured-Nation Tariff or a preferential tariff rate of customs duty under this Chapter that applies to those goods according to the tariff treatment applicable to their country of origin only after classification under a tariff item in Chapters 1 to 97 has been determined and the conditions of any Chapter 99 provision and any applicable regulations or orders in relation thereto have been met. 4. The words and expressions used in this Chapter have the same meaning as in Chapters 1 to 97. Issued January 1, 2020 99 - 1 CUSTOMS TARIFF - SCHEDULE Tariff Unit of MFN Applicable SS Description of Goods Item Meas. Tariff Preferential Tariffs 9901.00.00 Articles and materials for use in the manufacture or repair of the Free CCCT, LDCT, GPT, UST, following to be employed in commercial fishing or the commercial MT, MUST, CIAT, CT, harvesting of marine plants: CRT, IT, NT, SLT, PT, COLT, JT, PAT, HNT, Artificial bait; KRT, CEUT, UAT, CPTPT: Free Carapace measures; Cordage, fishing lines (including marlines), rope and twine, of a circumference not exceeding 38 mm; Devices for keeping nets open; Fish hooks; Fishing nets and netting; Jiggers; Line floats; Lobster traps; Lures; Marker buoys of any material excluding wood; Net floats; Scallop drag nets; Spat collectors and collector holders; Swivels.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,713,596 B2 Hong Et Al
    USOO9713596B2 (12) United States Patent (10) Patent No.: US 9,713,596 B2 Hong et al. (45) Date of Patent: Jul. 25, 2017 (54) BAKUCHOL COMPOSITIONS FOR FOREIGN PATENT DOCUMENTS TREATMENT OF POST INFLAMMATORY DE 1900 435 7, 1970 HYPERPGMENTATION DE 3417234 A1 * 11, 1985 JP H1171231 A * 3, 1999 ............... A61K 7.00 (75) Inventors: Mei Feng Hong, Lacey, WA (US); Qi JP 2000-327581 A 11 2000 Jia, Olympia, WA (US); Lidia Alfaro JP 2005325 120 A 11/2005 KR 2000-0007648 A 2, 2000 Brownell, Tacoma, WA (US) WO 2006/122160 A2 11/2006 WO 2008. 140673 A1 11, 2008 (73) Assignee: Unigen, Inc., Lacey, WA (US) (*) Notice: Subject to any disclaimer, the term of this OTHER PUBLICATIONS patent is extended or adjusted under 35 Ohno, O. Watabe, T., Kazuhiko, N., Kawagoshi, M., Uotsu, N., U.S.C. 154(b) by 0 days. Chiba, T., Yamada, M., Yamaguchi, K., Yamada, K., Miyamoto, K., Uemura, D. Inhibitory Effects of Bakuchiol, Bavachin, an (21) Appl. No.: 13/365,172 Isobavachalcone Isolated from Piper loungum on Melainin Produc (22) Filed: Feb. 2, 2012 tion in B 16 Mouse Melanoma Cells. Biosci. Biotechnol. Biochem. 74 (7), 1504-1506 (2010).* Prior Publication Data Hiroyuki Haraguchi, Junji Inoue, Yukiyoshi Tamura and Kenji (65) Mizutani.Antioxidative Components of Psoralea corylifolia US 2012/O2O1769 A1 Aug. 9, 2012 (Leguminosae). Phytother. Res. 16, 539-544 (2002).* Petra Clara Arck, et al. Towards a “free radical theory of graying: melanocyte apoptosis in the aging human hair follicle is an indicator Related U.S. Application Data of oxidative stress induced tissue damage.
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • Safety Data Sheet
    SAFETY DATA SHEET 1. Identification Product identifier TWINRIX ADULT Other means of identification Synonyms TWINRIX ADULT INJECTION 720 EL U AND 20 MCG/ML * TWINRIX SUSPENSION FOR INJECTION * TWINRIX ADULT PRE-FILLED SYRINGE * TWINRIX ERWACHSENE AMPULLE MIT 1 ML SUSPENSION * TWINRIX ERWACHSENE FERTIGSPRITZE MIT 1 ML SUSPENSION * HAB ADULT (720/20) * COMBINED HEPATITIS A/HEPATITIS B VACCINE * TWINRIX VACUNA COMBINADA ANTIHEPATITIS A Y B * TWINRIX VACUNA CONTRA LA HEPATITIS A Y B * TWINRIX ADULTO * AMBIRIX * HEPATITIS A VIRUS ANTIGEN (HM175) AND r-DNA HEPATITIS B SURFACE ANTIGEN (HBsAg) COMBINED VACCINE Recommended use Medicinal Product This safety data sheet is written to provide health, safety and environmental information for people handling this formulated product in the workplace. It is not intended to provide information relevant to medicinal use of the product. In this instance patients should consult prescribing information/package insert/product label or consult their pharmacist or physician. For health and safety information for individual ingredients used during manufacturing, refer to the appropriate safety data sheet for each ingredient. Recommended restrictions No other uses are advised. Manufacturer/Importer/Supplier/Distributor information COMPANY NAME GlaxoSmithKline US Address: 5 Moore Drive Research Triangle Park, NC 27709 USA Telephone: +1-888-825-5249 (General Inquiries) Email: [email protected] Website: www.gsk.com EMERGENCY CONTACTS CHEMTREC EMERGENCY NUMBERS Telephone: +(1) 703 527 3887 (International) 24/7; multi-language response Contract Number: CCN9484 VERISK 3E GLOBAL INCIDENT RESPONSE Telephone: +(1) 760 476 3971 (In country) +(1) 760 476 3962 or +(1) 866 519 4752 (International) 24/7; multi-language response Contract Number: 334878 2.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • Effect of Atropine on Denervated Rabbit Ear Blood Vessels
    http://www.paper.edu.cn Effect of Atropine on Denervated Rabbit Ear Blood Vessels *Shu-Qin Liu, *Wei-Jin Zang, *Zeng-Li Li, *Xiao-Jiang Yu, and †Bao-Ping Li similar to those of atropine and scopolamine. Henbane drugs Abstract: Surgical denervation of rabbit ear blood vessel beds was might exert multiple advantages in shock patients, but the va- combined with the isolated perfused rabbit ear technique to investi- sodilator effect is undoubtedly the main mechanism. Although gate the mechanism of atropine’s vasodilator action. Intramuscular many studies have been done throughout the world, the mecha- injection of atropine 0.2 mg/kg dilated the denervated blood vessels in the rabbit ear like innervated ones in vivo. Atropine at the maximal nisms of henbane drugs’ vasodilator action remain unclear. concentration (C )of3×10−6 to3×10−4 M did not increase ef- Atropine usually activates the central nervous system at max 8,9 fluent flow of the isolated perfused denervated rabbit ear under con- high doses. Scopolamine, in general, inhibits the central ner- −6 10–13 stant perfusion pressure, but chlorpromazine at a Cmax of 10 M and vous system at any dose. Anisodine slightly inhibits the acetylcholine (ACh) at 2.5 × 10−7 M significantly increased it and central nervous system compared with scopolamine.12,13 An- noradrenaline (NA) at 10−7 M significantly decreased it. Atropine at isodamine is so difficult to pass through the blood–brain bar- −7 −6 Cmax of3×10 M did not affect, but at3×10 M it abolished the rier that it might neither activate nor inhibit the central nervous −7 increase of the effluent flow induced by ACh 2.5 × 10 M.
    [Show full text]
  • In Vivo Effect of PC-SPES on Prostate Growth and Hepatic CYP3A Expression in Rats
    JPET Fast Forward. Published on April 3, 2003 as DOI: 10.1124/jpet.102.048645 JPETThis Fast article Forward. has not been Published copyedited and on formatted. April 3, The 2003 final asversion DOI:10.1124/jpet.102.048645 may differ from this version. JPET #48645 In Vivo Effect of PC-SPES on Prostate Growth and Hepatic CYP3A Expression in Rats Teri Wadsworth, Hataya Poonyagariyagorn, Elinore Sullivan, Dennis Koop and Charles E. Roselli. Downloaded from Department of Physiology and Pharmacology Oregon Health & Science University, Portland, OR. jpet.aspetjournals.org at ASPET Journals on September 26, 2021 1 Copyright 2003 by the American Society for Pharmacology and Experimental Therapeutics. JPET Fast Forward. Published on April 3, 2003 as DOI: 10.1124/jpet.102.048645 This article has not been copyedited and formatted. The final version may differ from this version. JPET #48645 Running Title: In vivo effects of PC-SPES Correspondence: Dr. Charles E. Roselli, Department of Physiology and Pharmacology L334, Oregon Health Sciences University, 3181 SW Sam Jackson Park Road, Portland, OR 97201-3098, Tel (503) 494-5837, FAX (503) 494-4352, email: [email protected] Number of text pages: 20 number of tables: 4 Downloaded from number of figures: 4 number of references: 40 jpet.aspetjournals.org number of words in the Abstract: 250 number of words the Introduction: 748 number of words in the Discussion: 1478 at ASPET Journals on September 26, 2021 nonstandard abbreviations: National Institute of Diabetes and Digestive and Kidney Disease (NIDDK);
    [Show full text]